← Back to Search

Prosthetic Device

Proprio Foot for Amputation (OPORP Trial)

N/A
Waitlist Available
Led By Sashwati Roy, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

OPORP Trial Summary

This trial is measuring the effects of powered prosthetic legs on the user's health and socket loading.

Eligible Conditions
  • Amputation
  • Prosthesis Durability
  • Dermabrasion
  • Limited Mobility
  • Pressure Sore
  • Foot Amputation
  • Limb Deficiencies
  • Prosthesis User

OPORP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effects of use of a powered transtibial prosthesis on socket pressure
Secondary outcome measures
Change in PEQ-13 Score
Change in Skin Perfusion
Change in transepidermal water loss
+1 more

OPORP Trial Design

2Treatment groups
Active Control
Group I: Proprio FootActive Control1 Intervention
microprocessor-controlled prosthesis that regulates the angle of ankle dorsiflexion during the swing phase
Group II: Empower AnkleActive Control1 Intervention
a powered prosthesis that provides active propulsion in late stance to mimic the positive work performed by the ankle plantar-flexors in push-off. The Empower has been shown to improve affected leg kinematics (increased ankle range of motion and reduced knee flexion) on smooth flat ground, ramp ascent, and gravel

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
983,155 Total Patients Enrolled
United States Department of DefenseFED
861 Previous Clinical Trials
227,188 Total Patients Enrolled
University of Notre DameOTHER
33 Previous Clinical Trials
61,588 Total Patients Enrolled

Media Library

Empower ankle by Ottobock (Prosthetic Device) Clinical Trial Eligibility Overview. Trial Name: NCT05112679 — N/A
Amputation Research Study Groups: Proprio Foot, Empower Ankle
Amputation Clinical Trial 2023: Empower ankle by Ottobock Highlights & Side Effects. Trial Name: NCT05112679 — N/A
Empower ankle by Ottobock (Prosthetic Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05112679 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been authorized to take part in this research?

"Affirmative. Clinicaltrials.gov's records show that this trial, which was posted on November 15th 2021, is presently searching for participants. 13 subjects need to be found at a single site."

Answered by AI

Are there still openings available for individuals to join this experiment?

"Affirmative. The information hosted on clinicaltrials.gov suggests that this study is actively searching for participants since its initial posting in November 2021 and most recent update in February 2022. A total of 13 individuals are required to be recruited from a single clinic location."

Answered by AI

Who else is applying?

What state do they live in?
Indiana
How old are they?
18 - 65
What site did they apply to?
Indiana University Health Methodist Hospital
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
~2 spots leftby Apr 2025